In what has been described as the largest case of health care fraud in U.S. history, British drugmaker GlaxoSmithKline Plc. agreed to plead guilty to criminal misdemeanor charges and pay $3 billion. Still awaiting court approval, it would settle allegations that the company broke U.S. laws in marketing and development of pharmaceuticals. GSK’s alleged misconduct includes marketing an antidepressant to patients under age 18 and failing to give the U.S. Food and Drug Administration safety data about its diabetes drug Avandia. The settlement agreement “is unprecedented in both size and scope,” said James Cole, the No. 2 official at the U.S. Justice Department. He called the action “historic” and “a clear warning to any company that chooses to break the law.”
GlaxoSmithKline settles healthcare fraud case for $3 billion (Reuters)
Comments
Special Features
2013 Outlook As we move into a transition year, check out LifeHealthPro's conjectures for the life, annuities, health and disability markets.
100 Best Sales & Marketing Ideas Whether you want ideas for referrals, generating leads or just listening to your clients better, we have the sales and marketing tips you need.
The Complete ELNY Saga For more than two decades, the Executive Life Insurance Company of New York (ELNY) has been bled for billions of dollars while languishing in a state-imposed purgatory.
Life Insurance A-Z This alphabetical-themed infographic will help your clients feel more comfortable discussing life insurance protection concepts.
2012 Advisor of the Year Through a very thorough nomination process we look to find a top producer who is a true cornerstone of a community.
Senior Survey 2011 In this special section, find out how seniors build their nest egg, make an estate plan, finance their health care and where they live.
